Literature DB >> 2527527

First International Symposium on Cilazapril Preclinical and Clinical Pharmacology. Lausanne, switzerland, May 5-7, 1988. Proceedings.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2527527      PMCID： PMC1379739     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Blockade of adrenergic potentiating effect of angiotensin by 1-Sar-8-Ala-angiotensin II.

Authors:  B G Zimmerman
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

2.  An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.

Authors:  H Gavras; H R Brunner; J H Laragh; J E Sealey; I Gavras; R A Vukovich
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

3.  Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure.

Authors:  H R Brunner; H Gavras; J H Laragh
Journal:  Lancet       Date:  1973-11-10       Impact factor: 79.321

4.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

5.  Renin activity in aortic tissue of rats.

Authors:  J Rosenthal; R Boucher; J M Rojo-Ortega; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1969-01       Impact factor: 2.273

6.  Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.

Authors:  S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

7.  Angiotensin-forming enzyme in brain tissue.

Authors:  D Ganten; J L Minnich; P Granger; K Hayduk; H M Brecht; A Barbeau; R Boucher; J Genest
Journal:  Science       Date:  1971-07-02       Impact factor: 47.728

8.  A specific orally active inhibitor of angiotensin-converting enzyme in man.

Authors:  R K Ferguson; G A Turini; H R Brunner; H Gavras; D N McKinstry
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

9.  Hypertension of renal origin: evidence for two different mechanisms.

Authors:  H R Brunner; J D Kirshman; J E Sealey; J H Laragh
Journal:  Science       Date:  1971-12-24       Impact factor: 47.728
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.